News
Neurooncologist Reena Thomas receives CIRM award of nearly $12 million for immunotherapy research
The award will facilitate a clinical trial testing the safety of CAR-T cells — immune cells from patients’ own bodies that have been bioengineered to destroy cancer cells — used to treat a deadly brain cancer.
Scientists employ AI to predict brain cancer outcomes
Stanford Medicine scientists and colleagues create an algorithm that could help physicians better understand and target complicated brain tumors.
Bioluminescence helps researchers develop cancer drugs for brain
A bioluminescent indicator glows when a cancer drug is active inside the brain, identifying which medications cross the blood-brain barrier.
Stanford University and The Invus Group collaborate to develop glioblastoma drugs
The collaboration will enable the development of medications to treat a type of brain cancer.
Wireless implant could help remove deadly brain tumors
Stanford Medicine researchers develop a first-of-its-kind wireless device that uses light-activated nanoparticles to kill cancer cells.